In vivo assessment of differential toxicity of cancer treatment drugs in Fanconi Anemia
Craig Dorrell, Sebastian Restrepo Cruz, Allison MacMillan, A. Mack Peters, Barbara Ann Burtness, Markus Grompe
The paper develops an in vivo mouse model to assess the differential toxicity of cancer drugs on Fanconi Anemia mutant hematopoietic cells and identifies drugs with neutral toxicity.
bioRxiv · Nov 21, 2025 · PreprintCancer Biology